Clinical outcome of microsurgical vasoepididymostomy versus epididymal or testicular sperm retrieval combined with intracytoplasmic sperm injection in obstructive azoospermia males
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This purpose of the retrospective study was to compare the clinical outcome of microsurgical
vasoepididymostomy (MVE) and sperm retrieval combined with intracytoplasmic sperm
injection (ICSI) in the treatment of males with obstructive azoospermia. From February
2018 to December 2019, a total of 69 males with obstructive azoospermia underwent
MVE while 351 males with obstructive azoospermia in their first ICSI cycles were enrolled.
Patients in the MVE group achieved higher pregnancy rate and births delivered rate
than those in ICSI group (pregnancy rate, 44.6% vs. 27.6% for MVE and ICSI, respectively;
delivery rate, 38.5% versus 25.8% for MVE and ICSI, respectively). Besides, lower
female age (<35 vs. ≥35 years old, OR 1.15, 95% CI = 1.08-1.21), higher sperm concentration
and forward motility after MVE((sperm concentration, OR (95% CI) = 1.12 (1.08-1.23),
sperm forward motility, OR (95% CI) = 1.10 (1.06-1.20)) were associated with higher
probability of pregnancy. Based on these data, it has been found that MVE is the prior
option for males with obstructive azoospermia suitable for the surgery, other than
direct subjected to ICSI. More high quality studies are needed in the future due to
the non-randomized design and the relative small size of this study.